ESR1 and lung carcinoma: α9-nAChR synergizes mainly with epidermal growth factor (EGF) receptor, insulin-like growth factor 1 (IGF-1) receptor, vascular endothelial growth factor (VEGF) receptor in lung cancer cells [56], and estrogen receptor α (ERα) in breast cancer cells [31].